Activation of the mutation in the mitogen-activated protein kinase (MAPK) pathway where the BRAF V600E gene is included, leads to the non-controlling tumor proliferation and thus, to the phenomenon of cell de-differentiation. Here, BRAF is linked to neoplasm.